Cardiovascular Risk Reduction: With the 2023 approval for reducing major adverse cardiovascular events, GLP-1 receptor agonists are now used within comprehensive cardiovascular risk-management strategies for patients with type 2 diabetes and established cardiovascular disease
We closely monitor each patients progress, adjusting their treatment plan as needed to ensure they achieve their weight loss goals without compromising their health
myBMI runs on a simple principle: safe, structured treatment guided by specialists
PubMed, Awuchi, Chinaza Godseill, et al
Department of Health and Human Services, weight loss and energy supplements were the leading cause of supplement-related emergency visits, following accidental ingestion of supplements by children
what matters is your consistency and ability to stick with the schedule long-term